Invention Grant
- Patent Title: Inhibitors of IRAK4 activity
-
Application No.: US15515383Application Date: 2015-09-25
-
Publication No.: US09969749B2Publication Date: 2018-05-15
- Inventor: Michael D. Altman , Brian M. Andresen , Jason D. Brubaker , Matthew L. Childers , Anthony Donofrio , Thierry Fischmann , Craig R. Gibeau , Solomon D. Kattar , Charles A. Lesburg , Jongwon Lim , John K. F. MacLean , Umar F. Mansoor , Alan B. Northrup , John M. Sanders , Luis Torres
- Applicant: MERCK SHARP & DOHME CORP.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Gloria M. Fuentes; Matthew A. Leff
- International Application: PCT/US2015/052111 WO 20150925
- International Announcement: WO2016/053771 WO 20160407
- Main IPC: C07D498/04
- IPC: C07D498/04 ; A61K45/06 ; A61K31/517 ; C07D403/04 ; C07D239/94 ; C07D401/04 ; A61K31/5377 ; C07D405/14 ; C07D401/14 ; C07D413/04 ; C07D405/04 ; C07D471/04 ; A61K31/5383 ; C07D491/048 ; C07D417/04 ; C07D409/04
Abstract:
The present invention relates to inhibitors of IRAK4 of Formula (I) and provides compositions comprising such inhibitors, as well as methods therewith for treating IRAK4-mediated or -associated conditions or diseases.
Public/Granted literature
- US20170275297A1 INHIBITORS OF IRAK4 ACTIVITY Public/Granted day:2017-09-28
Information query
